Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa

Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical microbiology 2020-02, Vol.69 (2), p.195-206
Hauptverfasser: Proctor, Chris R, McCarron, Paul A, Ternan, Nigel G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 206
container_issue 2
container_start_page 195
container_title Journal of medical microbiology
container_volume 69
creator Proctor, Chris R
McCarron, Paul A
Ternan, Nigel G
description Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation. QS is implicated in numerous human infections and consequently researchers have sought ways of effectively inhibiting the process in pathogenic bacteria. Two decades ago, furanones were the first class of chemical compounds identified as QS inhibitors (QSIs). is a ubiquitous organism, capable of causing a wide range of infections in humans, including eye and ear infections, wound infections and potentially fatal bacteraemia and thus novel treatments against this organism are greatly needed. This review provides a brief background on QS and the use of furanones as QSIs. Based on the effectiveness of action, both and we will explore the use of furanones as potential antimicrobial therapeutics and conclude with open questions.
doi_str_mv 10.1099/jmm.0.001144
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2344228907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2344228907</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-adc5317dc7b9184bfc42eea7685260eb2d148b67693868b133d1c8a25f6559533</originalsourceid><addsrcrecordid>eNo90DtPwzAYhWELgWgpbMzIIwMpvibxiCoKSJVggDlyki-tq8RufQHx7wlqYTrLozO8CF1TMqdEqfvtMMzJnBBKhThBUyoKnslciFM0JYSxjOVUTtBFCNvRFJyrczThVBVUEj5F3TJ5bZ0FvE_OpyELYIOxa2zsxtQmOh_wl4kbvHMRbDS6xzpg6z6hx3EDXu8gRdMErNfa2BDxW4DUusHZkWnwaW2sC_oSnXW6D3B13Bn6WD6-L56z1evTy-JhlTWcqZjptpGcFm1T1IqWou4awQB0kZeS5QRq1lJR1nmRK17mZU05b2lTaia7XEolOZ-h28Pvzrt9ghCrwYQG-l5bcClUjAvBWKlIMdK7A228C8FDV-28GbT_riipfstWY9mKVIeyI785Pqd6gPYf_6XkPyLidhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2344228907</pqid></control><display><type>article</type><title>Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa</title><source>MEDLINE</source><source>Microbiology Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Proctor, Chris R ; McCarron, Paul A ; Ternan, Nigel G</creator><creatorcontrib>Proctor, Chris R ; McCarron, Paul A ; Ternan, Nigel G</creatorcontrib><description>Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation. QS is implicated in numerous human infections and consequently researchers have sought ways of effectively inhibiting the process in pathogenic bacteria. Two decades ago, furanones were the first class of chemical compounds identified as QS inhibitors (QSIs). is a ubiquitous organism, capable of causing a wide range of infections in humans, including eye and ear infections, wound infections and potentially fatal bacteraemia and thus novel treatments against this organism are greatly needed. This review provides a brief background on QS and the use of furanones as QSIs. Based on the effectiveness of action, both and we will explore the use of furanones as potential antimicrobial therapeutics and conclude with open questions.</description><identifier>ISSN: 0022-2615</identifier><identifier>EISSN: 1473-5644</identifier><identifier>DOI: 10.1099/jmm.0.001144</identifier><identifier>PMID: 31971503</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Anti-Bacterial Agents - administration &amp; dosage ; Anti-Bacterial Agents - chemistry ; Furans - administration &amp; dosage ; Furans - chemistry ; Humans ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - genetics ; Pseudomonas aeruginosa - physiology ; Pseudomonas Infections - drug therapy ; Pseudomonas Infections - microbiology ; Quorum Sensing - drug effects</subject><ispartof>Journal of medical microbiology, 2020-02, Vol.69 (2), p.195-206</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-adc5317dc7b9184bfc42eea7685260eb2d148b67693868b133d1c8a25f6559533</citedby><cites>FETCH-LOGICAL-c329t-adc5317dc7b9184bfc42eea7685260eb2d148b67693868b133d1c8a25f6559533</cites><orcidid>0000-0002-0036-7123 ; 0000-0002-1788-7571 ; 0000-0002-2292-9887</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3733,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31971503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Proctor, Chris R</creatorcontrib><creatorcontrib>McCarron, Paul A</creatorcontrib><creatorcontrib>Ternan, Nigel G</creatorcontrib><title>Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa</title><title>Journal of medical microbiology</title><addtitle>J Med Microbiol</addtitle><description>Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation. QS is implicated in numerous human infections and consequently researchers have sought ways of effectively inhibiting the process in pathogenic bacteria. Two decades ago, furanones were the first class of chemical compounds identified as QS inhibitors (QSIs). is a ubiquitous organism, capable of causing a wide range of infections in humans, including eye and ear infections, wound infections and potentially fatal bacteraemia and thus novel treatments against this organism are greatly needed. This review provides a brief background on QS and the use of furanones as QSIs. Based on the effectiveness of action, both and we will explore the use of furanones as potential antimicrobial therapeutics and conclude with open questions.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Furans - administration &amp; dosage</subject><subject>Furans - chemistry</subject><subject>Humans</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - genetics</subject><subject>Pseudomonas aeruginosa - physiology</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Pseudomonas Infections - microbiology</subject><subject>Quorum Sensing - drug effects</subject><issn>0022-2615</issn><issn>1473-5644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90DtPwzAYhWELgWgpbMzIIwMpvibxiCoKSJVggDlyki-tq8RufQHx7wlqYTrLozO8CF1TMqdEqfvtMMzJnBBKhThBUyoKnslciFM0JYSxjOVUTtBFCNvRFJyrczThVBVUEj5F3TJ5bZ0FvE_OpyELYIOxa2zsxtQmOh_wl4kbvHMRbDS6xzpg6z6hx3EDXu8gRdMErNfa2BDxW4DUusHZkWnwaW2sC_oSnXW6D3B13Bn6WD6-L56z1evTy-JhlTWcqZjptpGcFm1T1IqWou4awQB0kZeS5QRq1lJR1nmRK17mZU05b2lTaia7XEolOZ-h28Pvzrt9ghCrwYQG-l5bcClUjAvBWKlIMdK7A228C8FDV-28GbT_riipfstWY9mKVIeyI785Pqd6gPYf_6XkPyLidhw</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Proctor, Chris R</creator><creator>McCarron, Paul A</creator><creator>Ternan, Nigel G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0036-7123</orcidid><orcidid>https://orcid.org/0000-0002-1788-7571</orcidid><orcidid>https://orcid.org/0000-0002-2292-9887</orcidid></search><sort><creationdate>202002</creationdate><title>Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa</title><author>Proctor, Chris R ; McCarron, Paul A ; Ternan, Nigel G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-adc5317dc7b9184bfc42eea7685260eb2d148b67693868b133d1c8a25f6559533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Furans - administration &amp; dosage</topic><topic>Furans - chemistry</topic><topic>Humans</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - genetics</topic><topic>Pseudomonas aeruginosa - physiology</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Pseudomonas Infections - microbiology</topic><topic>Quorum Sensing - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Proctor, Chris R</creatorcontrib><creatorcontrib>McCarron, Paul A</creatorcontrib><creatorcontrib>Ternan, Nigel G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Proctor, Chris R</au><au>McCarron, Paul A</au><au>Ternan, Nigel G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa</atitle><jtitle>Journal of medical microbiology</jtitle><addtitle>J Med Microbiol</addtitle><date>2020-02</date><risdate>2020</risdate><volume>69</volume><issue>2</issue><spage>195</spage><epage>206</epage><pages>195-206</pages><issn>0022-2615</issn><eissn>1473-5644</eissn><abstract>Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation. QS is implicated in numerous human infections and consequently researchers have sought ways of effectively inhibiting the process in pathogenic bacteria. Two decades ago, furanones were the first class of chemical compounds identified as QS inhibitors (QSIs). is a ubiquitous organism, capable of causing a wide range of infections in humans, including eye and ear infections, wound infections and potentially fatal bacteraemia and thus novel treatments against this organism are greatly needed. This review provides a brief background on QS and the use of furanones as QSIs. Based on the effectiveness of action, both and we will explore the use of furanones as potential antimicrobial therapeutics and conclude with open questions.</abstract><cop>England</cop><pmid>31971503</pmid><doi>10.1099/jmm.0.001144</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0036-7123</orcidid><orcidid>https://orcid.org/0000-0002-1788-7571</orcidid><orcidid>https://orcid.org/0000-0002-2292-9887</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2615
ispartof Journal of medical microbiology, 2020-02, Vol.69 (2), p.195-206
issn 0022-2615
1473-5644
language eng
recordid cdi_proquest_miscellaneous_2344228907
source MEDLINE; Microbiology Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Animals
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - chemistry
Furans - administration & dosage
Furans - chemistry
Humans
Pseudomonas aeruginosa - drug effects
Pseudomonas aeruginosa - genetics
Pseudomonas aeruginosa - physiology
Pseudomonas Infections - drug therapy
Pseudomonas Infections - microbiology
Quorum Sensing - drug effects
title Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A32%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Furanone%20quorum-sensing%20inhibitors%20with%20potential%20as%20novel%20therapeutics%20against%20Pseudomonas%20aeruginosa&rft.jtitle=Journal%20of%20medical%20microbiology&rft.au=Proctor,%20Chris%20R&rft.date=2020-02&rft.volume=69&rft.issue=2&rft.spage=195&rft.epage=206&rft.pages=195-206&rft.issn=0022-2615&rft.eissn=1473-5644&rft_id=info:doi/10.1099/jmm.0.001144&rft_dat=%3Cproquest_cross%3E2344228907%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2344228907&rft_id=info:pmid/31971503&rfr_iscdi=true